Exeliom Biosciences
PrivateLast Round
Grant
Nov 28, 2023
Total Funding Raised
$34.6M
Momentum Score
50 /100
Company Overview
Exeliom Biosciences is a biotechnology company focused on developing immunotherapies that leverage the therapeutic potential of gut microbiota through single bacterial strain drug candidates for treating inflammatory bowel diseases and cancer, beginning with Crohn's Disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exeliom Biosciences Comps
Public and private peers based on sector, stage, and business model.
Exeliom Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 28, 2023 | ||||
| Series A | Jun 30, 2023 | ||||
| Series A | Jul 5, 2018 |
Exeliom Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sofimac Innovation | Series A |
| National Research Institute for Agriculture, Food and Environment | Series A |
| Cap Innov'Est | Series A |
| Auriga Partners | Series A |
| Capital Grand Est | Series A |
| Crohn's & Colitis Foundation | Grant |
| CE-Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2025
Announced the launch of LIVEDIFF Part 2.
- Jun 30, 2023
$26M round completed.
Exeliom Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exeliom Biosciences's valuation, stock price, and market status.
